PGC1α expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress. - Wikidata - awgldk - TriplyDB

PGC1α expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress.

PGC1α expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress.

http://www.wikidata.org/entity/Q39193337

about

Melanoma: from melanocyte to genetic alterations and clinical options Clinical significance of T cell metabolic reprogramming in cancer Oncosuppressive functions of decorin Cancer stem cell metabolism Genetics and biology of pancreatic ductal adenocarcinoma Cross Talk of Proteostasis and Mitostasis in Cellular Homeodynamics, Ageing, and Disease Integration of Mitochondrial Targeting for Molecular Cancer Therapeutics Mitochondrial biogenesis and dynamics in the developing and diseased heart Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?Pathways and therapeutic targets in melanoma Targeting mitochondrial metabolism by inhibiting autophagy in BRAF-driven cancers Hypoxia-independent drivers of melanoma angiogenesis Targeting mitochondria metabolism for cancer therapy Transcriptional coregulators: emerging roles of SRC family of coactivators in disease pathology Metabolic rewiring in melanoma ROS homeostasis and metabolism: a dangerous liason in cancer cells Insights into the key roles of proteoglycans in breast cancer biology and translational medicine Decorin induces mitophagy in breast carcinoma cells via peroxisome proliferator-activated receptor γ coactivator-1α (PGC-1α) and mitostatin.Mitochondrial complex I inhibition triggers a mitophagy-dependent ROS increase leading to necroptosis and ferroptosis in melanoma cells ROS signaling under metabolic stress: cross-talk between AMPK and AKT pathway.Molecular pathways: BRAF induces bioenergetic adaptation by attenuating oxidative phosphorylation.Cryptolepine inhibits melanoma cell growth through coordinated changes in mitochondrial biogenesis, dynamics and metabolic tumor suppressor AMPKα1/2-LKB1.Expression of PGC1α in glioblastoma multiforme patients.Cyclin D1-Cdk4 controls glucose metabolism independently of cell cycle progression Caloric restriction and the aging process: a critique Flux balance analysis predicts essential genes in clear cell renal cell carcinoma metabolism.Adiponectin promotes pancreatic cancer progression by inhibiting apoptosis via the activation of AMPK/Sirt1/PGC-1α signaling.Updates of reactive oxygen species in melanoma etiology and progression.Hypoxia as a biomarker for radioresistant cancer stem cells.Inhibition of PI3K/AKT/mTOR axis disrupts oxidative stress-mediated survival of melanoma cells.Skin phototype: a new perspective.Nuclear receptor coactivators: master regulators of human health and disease.TRIM24 links glucose metabolism with transformation of human mammary epithelial cells Annonaceous acetogenin mimic AA005 induces cancer cell death via apoptosis inducing factor through a caspase-3-independent mechanism.Proteomic signatures associated with p53 mutational status in lung adenocarcinoma.Fbxl10 overexpression in murine hematopoietic stem cells induces leukemia involving metabolic activation and upregulation of Nsg2.Suppression of PGC-1α Is Critical for Reprogramming Oxidative Metabolism in Renal Cell Carcinoma Chromatin-Remodelling Complex NURF Is Essential for Differentiation of Adult Melanocyte Stem Cells.CD47 Receptor Globally Regulates Metabolic Pathways That Control Resistance to Ionizing Radiation Transcription Factor Tfe3 Directly Regulates Pgc-1alpha in Muscle

P2860

Q21284811-6CB94907-12EB-4994-B6E2-AB5F1DFFCEF5 Q26741974-5B3F709F-CC49-4B92-94B3-68210A91857A Q26745697-C923526E-E708-4C7C-AE76-FC275B580040 Q26746123-47FF01FD-C9EA-4377-909C-B47C7868C8E7 Q26765438-FDDA149B-9C25-445B-9150-23999F28C9B1 Q26765684-78D9732C-D98B-4CD0-844F-1E17AED8A5DD Q26771751-E6F1A239-1165-4294-8580-4BFC6BB82D0C Q26782031-333784BA-1610-4E81-83F6-CB3CF075F33E Q26852282-F302CEE5-E58A-4D5F-99B5-1A9799073171 Q26865736-7ADA2830-236D-460F-BCDA-82A1FA7B60B0 Q27022240-CF69115E-1018-414F-8DFE-6EE8F1BC1ABD Q27022246-529DFC9D-AB60-45E1-8D00-E9F6DA91B4DC Q27027219-5B7C0FBA-7FC8-4B16-8AD3-776EFB5B6D04 Q27030886-17560C7F-74CC-42F3-9D44-1F60CDF1FA18 Q28069081-5EECD2BF-5610-4ECF-9FF9-DE28283F6032 Q28075971-D8CE696F-7397-4244-9479-B3A3106A9E6F Q28085548-089E3CD8-02CE-4451-AC6F-84992B571F13 Q30572396-D4089949-673E-4354-A40D-13AC1D07B6BF Q30844792-500D40E9-B44D-4693-AA67-B9F61F9D2B90 Q33560337-4510ED7C-AB63-4FF3-826C-8B1B771B3B07 Q33560698-690DB995-4B3F-4585-929C-7F85398701ED Q33685458-9EB773C7-4300-4C7A-974E-130FF3861C98 Q33751236-4BCBE1CA-79F3-4329-BE6D-BDFC8E0BB29A Q33827309-2290C957-DEAA-4D6B-8C98-588D22E48537 Q33954183-CEB87E39-1A7B-4194-9404-5560E3C4CE4A Q34044149-4F3501C7-7F4B-43DC-B6A1-2B07A7F7B8B1 Q34104012-0F24A1B0-C9BB-495B-86CD-22EDD4F069B0 Q34403921-0FF85498-ED85-4BA6-BDAE-2BB8512955E0 Q34420732-1BD9A1EC-E475-44DA-9947-960F1B07D37B Q34466148-20E34D43-757F-4324-A53B-662A52B99B99 Q34467780-B3126DA4-963D-45EA-9290-95FD35048C0C Q35082574-2F6CE927-F2A7-44A1-BDAC-C5E991F8D5B5 Q35209056-206CAE25-5D86-4E64-BE15-74CC5F24D53A Q35233285-E119E95E-F1CE-4079-BC3D-D88927F31478 Q35492010-E32F65A3-A9E5-4945-8E1D-46A9468104EF Q35661995-5F8A17D8-DDF4-49C3-B7BF-0009878B90EF Q35899174-AF9550E9-8E56-467B-BFD3-25B521DC52AD Q36126538-C01C9E3E-9678-426A-B68D-743215242EC1 Q36139847-93F168CF-7FA9-4F53-BE21-4DC8FE6A19A5 Q36198477-61E17360-EF28-4109-825E-5C602420E1CA

P2860

PGC1α expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress.

http://www.wikidata.org/entity/Q39193337

description

2013 nî lūn-bûn

@nan

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

2013年论文

@zh

2013年论文

@zh-cn

name

PGC1α expression defines a sub ...... esistance to oxidative stress.

@en

PGC1α expression defines a sub ...... esistance to oxidative stress.

@nl

type

label

PGC1α expression defines a sub ...... esistance to oxidative stress.

@en

PGC1α expression defines a sub ...... esistance to oxidative stress.

@nl

prefLabel

PGC1α expression defines a sub ...... esistance to oxidative stress.

@en

PGC1α expression defines a sub ...... esistance to oxidative stress.

@nl

P1433

Q39193337-665FB505-0C8F-454D-9191-DD3E26C9F6CA

P1476

Q39193337-362EA2A2-82D8-4D34-9035-A190070F5096

P2093

Q39193337-19242703-C258-4B84-9103-0B5DB1D99F80

Q39193337-1ABE188D-E972-4319-A4E2-366B432EC756

Q39193337-218F04D5-604D-48CD-A6DF-79AAC8BB0F37

Q39193337-343DF685-AC20-4EBB-BF9C-42785043C506

Q39193337-72DDBAEB-8C64-4364-9774-5A0809D84955

Q39193337-744EFFF7-45A8-4930-8AF5-5577A2FBCAE0

Q39193337-8C1CDB92-484B-405E-9C97-DB82D715070A

Q39193337-D2F6C748-F0EA-4D26-938A-2EF7CD31B290

P2860

Q39193337-0A207248-ABAE-4DCE-8606-694E0C1F44A6

Q39193337-20BF7A9B-2E4B-4F89-8483-D5F78805DB88

Q39193337-274608AB-891A-4A31-8DA9-4FE777BB59B4

Q39193337-2977BA6B-64D2-4F66-A25A-82FC5E9AB4F1

Q39193337-2B0BCC97-9C52-4608-9E04-26EDC3483C5A

Q39193337-3D6A91A3-9B96-4A2B-9605-98816C76E897

Q39193337-42358768-7291-4853-8F2C-34B8DE96DD48

Q39193337-47EF7398-1594-48E0-B3FC-F826030CE383

Q39193337-49364517-6384-4B49-9341-CAA501C5FA7A

Q39193337-4B9A4287-4906-450C-963D-3E7B5D09A1EE

P304

Q39193337-442C4779-E3B3-4B9C-8D92-0803A02FAD9D

P31

Q39193337-091C7D21-02E0-464F-81F0-53FDB3EF478F

P356

Q39193337-99D6FECF-CB47-4FD1-AA7E-7F50BA2F9C11

P433

Q39193337-7F538219-97BA-4286-A5BE-4C8D4B13F637

P478

Q39193337-9C6F53D6-CF58-4928-A7FD-060C36ED029E

P50

Q39193337-2B7747F2-BE9D-4810-8A3B-259B2AD3E748

Q39193337-C29ACDDE-5680-4CC7-8BEB-9367692DA536

Q39193337-F39FEF7E-F553-4521-BC5D-B378EB65846C

P577

Q39193337-BCABB6B0-A18F-4140-9972-3946F73D05DE

P698

Q39193337-DD1D2337-D910-411C-8DFE-5578451FCF50

P921

Q39193337-C8466B0F-038C-4917-89C8-CAFC760D20EE

P932

Q39193337-D7EEC984-5597-49AE-888D-B75B845A2213

P356

J.CCR.2012.11.020

P1433

P1476

PGC1α expression defines a sub ...... resistance to oxidative stress

@en

P2093

Bruce M Spiegelman

http://www.w3.org/2001/XMLSchema#string

Geoff Girnun

http://www.w3.org/2001/XMLSchema#string

Helen Chim

http://www.w3.org/2001/XMLSchema#string

Ji-Hong Lim

http://www.w3.org/2001/XMLSchema#string

Kavita Bhalla

http://www.w3.org/2001/XMLSchema#string

Kerry Pierce

http://www.w3.org/2001/XMLSchema#string

Pere Puigserver

http://www.w3.org/2001/XMLSchema#string

Scott R Granter

http://www.w3.org/2001/XMLSchema#string

P2860

Hallmarks of Cancer: The Next Generation

PGC-1, a versatile coactivator

Peroxisome proliferator-activated receptor-gamma coactivator 1 alpha (PGC-1 alpha): transcriptional coactivator and metabolic regulator

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.

Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle

The estrogen-related receptor alpha (ERRalpha) functions in PPARgamma coactivator 1alpha (PGC-1alpha)-induced mitochondrial biogenesis

RETRACTED: Selective killing of cancer cells by a small molecule targeting the stress response to ROS

Cancer related mutations in NRF2 impair its recognition by Keap1-Cul3 E3 ligase and promote malignancy

A cold-inducible coactivator of nuclear receptors linked to adaptive thermogenesis

Genomic analysis of metastasis reveals an essential role for RhoC

P304

287-301

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CCR.2012.11.020

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

23

http://www.w3.org/2001/XMLSchema#string

P50

Hans R. Widlund

Francisca Vazquez

P577

2013-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

23416000

http://www.w3.org/2001/XMLSchema#string

P921

P932

3708305

http://www.w3.org/2001/XMLSchema#string